On Monday, the U.S. National Institutes of Health (NIH) announced they had started the first human trial of a possible vaccine for SARS-CoV-2, the coronavirus behind covid-19, with the first test subject receiving their shot that very day. But while this trial, based in Seattle, and other upcoming ones are certainly good news, it will still take lots of time and good luck for any vaccine to reach the public.
More Articles with Peter Hotez
- New University of Pennsylvania study says Harris County might have drastic rise in COVID-19 cases in next few weeks – ABC13 Houston
- Coronavirus ‘immunity passports’ are a terrible idea that could backfire, experts warn – KTVZ
- Vaccine expert Peter Hotez reveals 3 things to help Houston reopen, avoid second surge of COVID-19 – HoustonChronicle.com